Position in URGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,262,915
+$434,011 QoQ
Shares Held
70,240
+98.5% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. URGN ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
178,779 | $33,798,169 | |
| 2 | INSM |
INSMED Inc
|
148,133 | $24,222,708 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
227,084 | $17,051,737 | |
| 4 | ABVX |
Abivax S.A.
|
140,262 | $15,618,173 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
372,175 | $14,325,015 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
317,351 | $12,767,030 | |
| 7 | BHVN |
Biohaven Ltd.
|
1,501,099 | $12,699,297 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
173,425 | $10,084,663 |
All Filings in URGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,262,915 | 70,240 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $828,904 | 35,393 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $330,032 | 16,543 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $357,818 | 33,598 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||